Health & Science

A promising new approach to AIDS; Why some old people stay sharp; A transplant milestone; Watch a lot of TV? How sad; Kids: Living well with technology

A promising new approach to AIDS

The startling case of an AIDS patient who appears to have been cured is raising new hopes for a breakthrough in the treatment of the disease. In a delicate and risky procedure, doctors in Germany killed all of the patient’s diseased bone marrow with radiation and then introduced a new population of bone marrow stem cells from a donor who is genetically resistant to HIV. The new immune cells appear to have rid the patient’s body of HIV. More than 600 days after the operation, the unidentified 42-year-old patient still appears to be virus-free, though doctors caution that the virus could be dormant and reappear. Doctors also note that bone marrow transplants are extremely expensive and dangerous procedures that kill a third of patients who receive them, and that the only reason the procedure was justified in this case was because the patient also has leukemia. All those caveats aside, researchers say the German case suggests a potential new therapeutic avenue using gene therapies to modify patients’ immune systems so that they can defeat HIV. It’s not quite a eureka moment, University of Massachusetts AIDS expert Mario Stevenson tells Science. But “it’s proof of the concept of gene therapy.”

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us